Physician profile
Daniel Miller
NPI 1336598473
$9,873.26
in general payments reported to CMS, 2019-2025
15 companies · $304 in 2025
The $304 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $621 · 2020: $435 · 2021: $731 · 2022: $4,700 · 2023: $1,534 · 2024: $1,548 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,048 · Food and Beverage: $1,189 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,048.05 |
| Food and Beverage | $1,188.51 |
| Education | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,327.64 | 2022-2024 | |
| Reel Surgical, INC. | $2,523.99 | 2020-2024 | |
| United Orthopedics LLC | $1,225.83 | 2022 | |
| Medical Device Business Services, INC. | $1,019.96 | 2019-2021 | |
| Stryker Corporation | $608.57 | 2020-2025 | Alphavent |
| Miach Orthopaedics, INC. | $594.87 | 2022-2025 | |
| Edwards Lifesciences Corporation | $134.70 | 2019 | |
| Wright Medical Technology, INC. | $125.10 | 2019 | |
| Linvatec Corporation | $106.55 | 2024 | Biobrace 23mm |
| Depuy Synthes Sales INC. | $71.51 | 2025 | Fms |
| Acumed LLC | $44.68 | 2023 | Acumed, Osteomed |
| Polynovo North America LLC | $28.40 | 2025 | Novosorb Btm |
| Vericel Corporation | $27.16 | 2022 | |
| Acell, INC. | $23.30 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.